Chimeric Human Papillomavirus-16 Virus-like Particles Presenting HIV-1 P18I10 Peptide: Expression, Purification, Bio-Physical Properties and Immunogenicity in BALB/c Mice

Human papillomavirus (HPV) vaccines based on HPV L1 virus-like particles (VLPs) are already licensed but not accessible worldwide. About 38.0 million people were living with HIV in 2020 and there is no HIV vaccine yet. Therefore, safe, effective, and affordable vaccines against both viruses are an u...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chun-Wei, Saubi, Narcís, Joseph-Munné, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179162/
https://www.ncbi.nlm.nih.gov/pubmed/37175776
http://dx.doi.org/10.3390/ijms24098060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179162/
https://www.ncbi.nlm.nih.gov/pubmed/37175776
http://dx.doi.org/10.3390/ijms24098060

Ejemplares similares